ENT Liu Knowledge Base Head & neck tumours · physician reviewed
Head and Neck Cancer of Unknown Primary · Understanding the disease

Where in the world is head and neck cancer of unknown primary most common?

Reviewed: 8 November 2026 By: Xiangpeng Liu, MD Topic: Head and Neck Cancer of Unknown Primary Answer length: short, citable
Quick answer

Head and Neck Cancer of Unknown Primary is not evenly distributed: the highest-burden regions are North America, Northern Europe & UK and South-East Asia & North Africa. In 2022 there were about 2–5% of head and neck squamous cell carcinoma presentations worldwide (no separate global ASR — cases are coded to the metastatic site, not the hidden primary), with marked country-to-country variation driven by local exposures such as tobacco, areca nut, oncogenic viruses, ultraviolet radiation and occupational carcinogens.

In detail

The regional pattern matters clinically. A patient from North America may present with a different risk-factor profile and a different stage distribution than a patient from a low-incidence country, which changes both the differential diagnosis and the pretreatment work-up.

All incidence figures on this site are age-standardised rates or absolute case counts from GLOBOCAN 2022 and its subsite analyses. They describe populations, not individual risk.

  • North America: Oropharyngeal cancer makes up 43.8% of the region’s lip/oral/pharyngeal burden and about 70% of US oropharyngeal cancers are HPV-positive — the main reason occult tonsil/base-of-tongue primaries are frequently encountered.
  • Northern Europe & UK: High HPV-attributable fractions (52–77%) produce the same pattern of small, node-positive, visually occult primaries in younger non-smokers.
  • South-East Asia & North Africa: Nasopharyngeal carcinoma is the hidden primary to exclude; plasma EBV DNA, nasopharyngoscopy and MRI of the nasopharynx are essential.
  • Australia & New Zealand: Both HPV-related oropharyngeal cancer and UV-related head and neck skin cancer are common, so scalp, ear and facial skin must be examined as possible primaries.
  • South Asia: Oral cavity and hypopharyngeal cancers dominate; careful oral and panendoscopic examination is needed to exclude a small mucosal primary.

What this means in practice: this answer is part of the “Understanding the disease” section of the Head and Neck Cancer of Unknown Primary topic. If you are comparing treatment options, also read how to compare a second opinion and which records to send.

Other common questions about head and neck cancer of unknown primary

See all 13 questions in this topic →

Sources for this answer

  1. Global incidence of lip, oral cavity, and pharyngeal cancers by subsite in 2022 CA: A Cancer Journal for Clinicians · 2026 · Subsite-level estimates for 185 countries; the basis of the regional atlas on this site.
  2. Global Cancer Observatory (GLOBOCAN 2022) International Agency for Research on Cancer / WHO · 2022 · Source of worldwide and country-level incidence and mortality estimates.
  3. Global Cancer Facts & Figures, 5th Edition (GLOBOCAN 2022 tables) American Cancer Society · 2024
  4. HPV & Oropharyngeal Cancer US National Institute of Dental and Craniofacial Research · 2025 · About 70% of oropharyngeal cancers in the United States are HPV-positive.
  5. HPV Detection in Oropharyngeal Cancer: A Narrative Review PubMed Central / peer-reviewed review · 2025 · HPV-attributable fraction: ~71% US, ~52% UK, >60% Scandinavia, <20% Southern Europe, ~44% globally.
  6. NCCN Guidelines for Patients: Head and Neck Cancers National Comprehensive Cancer Network · 2025
  7. Head and Neck Cancers (patient information) US National Cancer Institute · 2025

Written and medically reviewed by Xiangpeng Liu, MD

Associate Chief Physician, ENT & Head/Neck Surgery · Chenzhou First People’s Hospital, Chenzhou, Hunan, China

Editorial policy & reviewer credentials · All sources

← Previous questionWhat is head and neck cancer of unknown primary? Next question →What are the risk factors for head and neck cancer of unknown primary?

Need an opinion on your own case?

International patients can request a preliminary review based on pathology and imaging before travelling to China.

How the pathway works Send an enquiry

Medical disclaimer: This knowledge base is general information for people researching head and neck tumours, not a diagnosis or treatment plan. It does not replace an examination by a qualified physician. Survival figures are population averages, not predictions for an individual. Treatment and cost estimates for China are illustrative only and must be confirmed in writing after your records have been reviewed. If you have a symptom lasting more than two to three weeks, see a doctor promptly.